Hepion Pharmaceuticals, Inc.
Long
Updated

Extremely undervalued

1 045
Overreaction to their public offering. Their cash balance would already be higher than their market cap once the offering is closed.
Note
Have closed the position for other trades

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.